Darifenacin
These highlights do not include all the information needed to use DARIFENACIN EXTENDED RELEASE TABLETS safely and effectively. See full prescribing information for DARIFENACIN EXTENDED RELEASE TABLETS.DARIFENACIN extended-release tablets, for oral useInitial U.S. Approval: 2004
6e8470d1-c3e6-4644-b70a-aa47ddf79676
HUMAN PRESCRIPTION DRUG LABEL
Aug 16, 2021
Cipla USA Inc.
DUNS: 078719707
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Darifenacin Hydrobromide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
Darifenacin Hydrobromide
Product Details
FDA regulatory identification and product classification information